Publication & Citation Trends
Publications
0 total
P41 Assessment of cognitive function in a randomized, placebo-controlled, interventional trial conducted in patients with moderate-to-severe systemic lupus erythematosus (SLE) OA
Cited by 0
Semantic Scholar
LO-021 Interim safety and efficacy of subcutaneous (s.c.) dose ianalumab (VAY736; anti-BAFF-R mAb) administered monthly over 28 weeks in patients with systemic lupus erythematosus (SLE) OA
Cited by 0
Semantic Scholar
Efficacy and safety of MAS825 (anti-IL-1ꞵ/IL-18) in COVID-19 patients with pneumonia and impaired respiratory function. OA
Cited by 10
Semantic Scholar
Pharmacokinetics and Safety of Multiple-Dose Alpelisib in Participants with Moderate or Severe Hepatic Impairment: A Phase 1, Open-Label, Parallel Group Study OA
Cited by 3
Semantic Scholar
Evaluation of the Pharmacokinetic Drug Interaction of Capmatinib With Itraconazole and Rifampicin and Potential Impact on Renal Transporters in Healthy Subjects OA
Cited by 3
Semantic Scholar
Pharmacokinetics of asciminib in the presence of CYP3A or P‐gp inhibitors, CYP3A inducers, and acid‐reducing agents OA
Cited by 9
Semantic Scholar
Pharmacokinetic drug interactions of asciminib with the sensitive cytochrome P450 probe substrates midazolam, warfarin, and repaglinide in healthy participants OA
Cited by 14
Semantic Scholar
Research Topics
Chronic Myeloid Leukemia Treatments
(5)
Systemic Lupus Erythematosus Research
(2)
Pharmacogenetics and Drug Metabolism
(2)
Chronic Lymphocytic Leukemia Research
(2)
COVID-19 Clinical Research Studies
(1)
Affiliations
Novartis (Switzerland)
Novartis (India)